A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer

INTRODUCTION: This is a retrospective analysis to assess the safety and efficacy of abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC) patients treated at tertiary care institute. MATERIALS AND METHODS: The clinical records of mCRPC patients treated with AA at our tert...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:South Asian J Cancer
Prif Awduron: Joshi, Amit, Shrirangwar, Sameer, Noronha, Vanita, Sable, Nilesh, Agarwal, Archi, Popat, Palak, Bhattacharjee, Atanu, Prabhash, Kumar
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wolters Kluwer - Medknow 2020
Pynciau:
ORIGINAL ARTICLE: Genitourinary Cancers
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956584/
https://ncbi.nlm.nih.gov/pubmed/31956615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_433_18
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg